α-Ethyldopamine

α-Ethyldopamine
Clinical data
Other names	α-Ethyl-3,4-dihydroxyphenethylamine; DH-α-Et-PEA; AEDP; AED; 1,2-Dihydroxy-4-(2-amino-butyl)benzene
ATC code	None;
Identifiers
	IUPAC name 4-(2-aminobutyl)benzene-1,2-diol;
PubChem CID	20329954;
ChemSpider	97479570;
Chemical and physical data
Formula	C10H15NO2
Molar mass	181.235 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCC(CC1=CC(=C(C=C1)O)O)N;
	InChI InChI=1S/C10H15NO2/c1-2-8(11)5-7-3-4-9(12)10(13)6-7/h3-4,6,8,12-13H,2,5,11H2,1H3; Key:ZVTVIPHSXNUZQH-UHFFFAOYSA-N;

α-Ethyldopamine (α-ethyl-3,4-dihydroxyphenethylamine; AED; AEDP) also known by the abbreviation DHABB, is a phase I metabolite of the drug benzodioxolylbutanamine (BDB) in humans. It is metabolised by the enzymes CYP2D6 and CYP3A4.^[1]

References

↑ Meyer MR, Peters FT, Maurer HH (October 2009). "Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers". Toxicology Letters. 190 (1): 54–60. Bibcode:2009ToxL..190...54M. doi:10.1016/j.toxlet.2009.06.866. PMID 19576971.

External links

α-Ethyl-3,4-dihydroxyphenethylamine (DH-α-Et-PEA) - Isomer Design

This pharmacology-related article is a stub. You can help Wikipedia by adding missing information.

[1] Meyer MR, Peters FT, Maurer HH (October 2009). "Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers". Toxicology Letters. 190 (1): 54–60. Bibcode:2009ToxL..190...54M. doi:10.1016/j.toxlet.2009.06.866. PMID 19576971.

[1]

See also

References

External links